Surgical Aid to Patients with Hepatopancreatobiliary Situations in Precovid Period and under Persistent Relapse of New Coronavirus Infection SARS-CoV-2

Introduction. The third wave of the new coronavirus infection (COVID-19) pandemic warrants total mobilisation of healthcare and social resources. In this respect, a pressing issue remains the provision of routine and emergency surgical care in patients with hepatopancreatobiliary diseases.

Materials and methods. A retrospective analysis of the surgical outcomes in 5,040 hepatopancreatobiliary patients was carried out; this accounted for 51.1 % of the total abdominal surgeries.

Results and discussion. Biliary lithiasis and its complications — choledocholithiasis with obstructive jaundice and residual choledocholithiasis — (54.4 %) as well as acute calculous cholecystitis (18.7 %) were operated most frequently. A sharp decrease over all hepatopancreatobiliary nosologies was registered for the surgical interventions in first pandemic year 2020. Thus, the median annual number of operations for biliary lithiasis and its complications was 550 (482–592 year-range) in the precovid period, while dropping to only 321 at the onset of pandemic (p <0.05). A first sixmonth survey of year 2021 revealed a growth of surgical activity for all hepatopancreatobiliary nosologies.

Conclusion. Hepatopancreatobiliary operations prevail (54.4 % cases) in the total structure of level 3 abdominal surgical interventions. A high annual rate of surgical operations over nearly all hepatopancreatobiliary nosologies was interrupted in the first year of the new coronavirus infection outbreak. Meanwhile, the first half of 2021 showed a clear tend towards restoring the precovid statistical indicators, despite the stressful conditions of persistently relapsing COVID-19 that surgical facilities had faced.

1. WHO Director-General’s opening remarks at the media briefing on COVID-19. 11 march 2020. World Health Organization. Available at: https://www.who.int/director-general/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed 5 February 2022).

2. COVID-19 Dashboard by the Center for Systems and Engineering (CSSE) at Johns Hopkins University (JHU). Public Health Update. Available at: https://publichealthupdate.com/jhu/ (accessed 20 July 2021).

3. Timerbulatov M.V., Aitova L.R., Grishina E.E., Vizgalova A.E., Ziganshin T.M., Garifullin A.A., et al. Provision of population with surgical aid under COVID-19 pandemic. Bashkortostan Medical Journal. 2020;15(3(87)):12–7 (In Russ.).

4. Timerbulatov V.M., Timerbulatov M.V., Plechev V.V., Victorov V.V., TImerbulatov SH.V., Gafarova A.R., et al. Surgery during and after COVID-2019 pandemi. Bashkortostan Medical Journal. 2020;15(3(87)):17–21 (In Russ.).

5. Pavlov V.N., Bulatov SH.E., Viktorov V.V., Efremova O.A., Tyurin A.V., Khusainova L.N., et al. On the provision of medical care to patientswith a new coronavirus infection COVID-19 in a hospital on the basis of the BSMU clinic. Bashkortostan Medical Journal. 2020;15(3(87)):9–12 (In Russ.).

6. Starshinova A.A., Kushnareva E.A., Kudlay D.A., Dovgalyuk I.F. Prospects for a COVID-19 treatment: review. Translational Medicine. 2020;7(3):30–7 (In Russ.) DOI: 10.18705/2311-4495-2020-7-3-30-37

7. Avilov O.V. Principle and modules of the step-by-step risk assessment for non-communicable diseases. Healthcare, education and security. 2019;1(17):97–105 (In Russ.).

8. Smok A.M., Malkova A.M., Kudlay D.A., Starshinova A.A. Possibilities for correcting hepatotoxic reactions during therapy in patients with COVID-19 (case report). Translational Medicine. 2020;7(6):65–72 (In Russ.). DOI: 10.18705/2311-4495-2020-7-6-65-72

9. Glavatskih R.A., Davidova N.S., Leyderman I.N., Sobetova G.V. Clinical effects of adaptive lung ventilation regime during weaning of mixed ICU patients. Translational Medicine. 2022;9(1):39–48 (In Russ.). DOI: 10.18705/2311-4495-2022-9-1-39-48

10. Vasilchenko A.V., Samorodova A.I. To the question of education of healthcare workers on criminal liability for improper performance of their professional duties. Healthcare, education and security. 2020;3(23):105–14 (In Russ.).

11. Pryor A. SAGES and EAES recommendations regarding surgical responseto COVID-19 crisis. SAGES: Society of American Gastrointestinal and Endoscopic Surgeons. Available at: htts://www.sages.org/recommendations-surgical-response-covid-19. (accessed 15 December 2020).

12. Valishin D.A., Murzabayeva R.T., Galimov R.R., Galieva A.T., Galieva R.A., Shaykhullina L.R., et al. The main criteria for determining the tactics of management of patients with novel coronavirus infection COVID-19. Bashkortostan Medical Journal. 2021;16(1(91)):61–6 (In Russ.).

13. Khasanov A.G., Sufiyarov I.F., Menshikov A.M., Sendik A.I., Badretdinov A.F., Sagadatova Yu.R. Experience of surgical treatment of patients against the background of a new coronavirus infection. Bashkortostan Medical Journal. 2021;16(1(91)):86–90 (In Russ.).

14. Panteleyev V.S., Nartailakov M.A., Mustafin A.Kh., Gabdrakhimov S.R., Musharapov D.R. Laser irradiation in treatment for hepatic alveococcosis. Bashkortostan Medical Journal. 2011;6(3):46–9 (In Russ.).

15. Nartaylakov M.A., Ibadildin A.S., Panteleev V.S., Salimgareev I.Z., Galimov I.I., Muhamedzhanov G.K., et al. Prevention and treatment of postoperative complications of liver echinococcosis and alveococcosis. Bulletin of surgery in Kazakhstan. 2017;1(50):27–30 (In Russ.).